FYERS
Home
/
Stocks
/
Profit Loss
/
Sudeep Pharma Profit & Loss

Sudeep Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
₹158 Cr₹182 Cr₹172 Cr₹163 Cr₹125 Cr₹158 Cr₹116 Cr₹149 Cr
₹5 Cr₹6 Cr₹7 Cr₹10 Cr₹5 Cr₹4 Cr₹2 Cr₹2 Cr
₹164 Cr₹189 Cr₹179 Cr₹173 Cr₹130 Cr₹161 Cr₹118 Cr₹151 Cr
₹107 Cr₹124 Cr₹116 Cr₹111 Cr₹84 Cr₹102 Cr₹79 Cr₹88 Cr
₹60 Cr₹69 Cr₹67 Cr₹66 Cr₹49 Cr₹63 Cr₹42 Cr₹65 Cr
₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr
₹54 Cr₹63 Cr₹62 Cr₹60 Cr₹44 Cr₹58 Cr₹38 Cr₹62 Cr
₹41 Cr₹49 Cr₹48 Cr₹47 Cr₹31 Cr₹44 Cr₹29 Cr₹49 Cr

Share Price Live Stats

Open (₹)1,369.20
Volume (₹)410.00
High (₹)1,369.20
Upper Circuit1,395.70
Low (₹)1,329.30
Lower Circuit1,262.90
Prev Close1,292.80
52W High (₹)1,369.20
Price1,329.30
52W Low (₹)524.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)14630.80 Cr
Div. Yield (%)0.12
PE Ratio80.11
Debt to Equity0.17
Price to Book7.57
Book Value78.21
EPS (TTM)16.17
Face Value1.00
ROE (%)25.37

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
SUDEEPPHRMNSE
LTP
1W Low
1W High
Market cap (₹)
1963+31.3 (1.62%)
1881.80
2183.80
4,56,833Cr
9555+335 (3.63%)
8750
10010
2,45,426Cr
4857-155 (-3.09%)
4711.50
5252.50
1,87,320Cr
1119.9-34.3 (-2.97%)
1086.40
1230
1,13,217Cr
1499+86.2 (6.10%)
1300
1523.50
1,12,212Cr
1784.8-79.2 (-4.25%)
1697.20
2024
1,01,155Cr
2321+165.8 (7.69%)
2004.50
2321
97,626Cr
2560.6+169.1 (7.07%)
2317
2560.60
96,859Cr
1279.8+123.3 (10.66%)
1151
1279.80
96,406Cr
1653.1+4.9 (0.30%)
1603.50
1818.40
93,614Cr
1329.3+95.3 (7.72%)
1143.65
1369.20
14,631Cr

Key Highlights of Sudeep Pharma Ltd’s P&L

In 2026-03-31, Sudeep Pharma Ltd reported total revenue of ₹670.84Cr, compared with ₹511.33Cr in 2025-03-31, reflecting Sudeep Pharma Ltd turnover.

Depreciation was ₹14.81Cr and finance costs were ₹8.5Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹228.07Cr in 2026-03-31 as compared to ₹182.84Cr in 2025-03-31.

Net Profit (PAT) was ₹172.89Cr in 2026-03-31 compared with ₹138.73Cr in 2025-03-31.

Earnings per share (EPS) were ₹15.31 in 2026-03-31, compared with ₹14.27 in 2025-03-31.